The microbiome and the hallmarks of cancer
Open accessThe DOI matches its Crossref record; 160 of the 161 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
How does the microbiota influence cellular proliferation and host cellular energetics?Normal tissues tightly regulate growth-promoting and death-inducing signals to maintain homeostatic cell densities, tissue architecture, and function.Dysregulation of these signaling pathways can lead to sustained cellular proliferation.The intercellular adhesion molecule, Ecadherin, is a common target engaged by intestinal bacteria that promotes epithelial proliferation by activating the Wnt/ß-catenin pathway.For example, enterotoxigenic Bacteroides fragilis (ETBF), resident among the microbiota of some individuals, secretes B. fragilis toxin (BFT)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, the gut microbiome can either be tumor-suppressive or oncogenic [22,23].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [22]
In the citing paper
“Several commensal bacteria play a probiotic role thanks to their capability to confer health benefits, either protecting against gut dysbiosis or enhancing host’s immune defense mechanisms [22,24].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488
Cited by
The microbiome and human cancer
Sepich-Poore, G. D., Zitvogel, L., Straussman, R., Hasty, J., Wargo, J. A., & Knight, R. (2021) · Science · doi:10.1126/science.abc4552 · Cited by 1,332
Silver nanoparticles: Synthesis, medical applications and biosafety
Xu, L., Wang, Y.-Y., Huang, J., Chen, C.-Y., Wang, Z.-X., & Xie, H. (2020) · Theranostics · doi:10.7150/thno.45413 · Cited by 1,315
“Migration and invasion are important hallmarks of cancer progression and deterioration [270].”
BackgroundGut Microbiota and Cancer: From Pathogenesis to Therapy
Vivarelli, S., Salemi, R., Candido, S., Falzone, L., Santagati, M., Stefani, S., Torino, F., Banna, G. L., Tonini, G., & Libra, M. (2019) · Cancers · doi:10.3390/cancers11010038 · Cited by 586
“Several commensal bacteria play a probiotic role thanks to their capability to confer health benefits, either protecting against gut dysbiosis or enhancing host’s immune defense mechanisms [22,24].”
BackgroundThe microbiome and gynaecological cancer development, prevention and therapy
Łaniewski, P., Ilhan, Z. E., & Herbst-Kralovetz, M. M. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0286-z · Cited by 450
Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer
Cani, P. D., & Jordan, B. F. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0025-6 · Cited by 383
Ilhan, Z. E., Łaniewski, P., Thomas, N., Roe, D. J., Chase, D. M., & Herbst-Kralovetz, M. M. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.04.028 · Cited by 299
“Microbe-microbeandhost-microbeinteractionsthroughmetabolicnet-works can shape the local tumour environment [64], hence dysbiotic vaginalmicrobiome-mediatedmetabolomehas thepotentialtobecome a hallmark of cervical cancer.”
Bacterial infections and cancer
van Elsland, D., & Neefjes, J. (2018) · EMBO reports · doi:10.15252/embr.201846632 · Cited by 213
“It is also known that bacterial effectors from different species can act synergistically during host cell manipulation and then act in a symbiotic inter-species manner [55,97].”
Exploiting bacteria for cancer immunotherapy
Kwon, S.-Y., Thi-Thu Ngo, H., Son, J., Hong, Y., & Min, J.-J. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00908-9 · Cited by 201
“of the diversity and functional importance of the microbiome of solid tumours 13,14,16,19–21 .”
Fusobacterium nucleatum and oral cancer: a critical review
McIlvanna, E., Linden, G. J., Craig, S. G., Lundy, F. T., & James, J. A. (2021) · BMC Cancer · doi:10.1186/s12885-021-08903-4 · Cited by 198
Takáč, P., Michalková, R., Čižmáriková, M., Bedlovičová, Z., Balážová, Ľ., & Takáčová, G. (2023) · Life · doi:10.3390/life13020466 · Cited by 189
Kovács, T., Mikó, E., Vida, A., Sebő, É., Toth, J., Csonka, T., Boratkó, A., Ujlaki, G., Lente, G., Kovács, P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37664-7 · Cited by 187
Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by IL-1Ra
Ji, D. X., Yamashiro, L. H., Chen, K. J., Mukaida, N., Kramnik, I., Darwin, K. H., & Vance, R. E. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0578-3 · Cited by 182
Starvation, Stress Resistance, and Cancer
Buono, R., & Longo, V. D. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.01.008 · Cited by 162
Role of Reactive Oxygen Species in Aging and Age-Related Diseases: A Review
Anik, M. I., Mahmud, N., Masud, A. A., Khan, M. I., Islam, M. N., Uddin, S., & Hossain, M. K. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00411 · Cited by 172
Mitochondria, the gut microbiome and ROS
Ballard, J. W. O., & Towarnicki, S. G. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109737 · Cited by 158
Microbiome evolution during host aging
Aleman, F., & Valenzano, D. R. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007727 · Cited by 149
Venanzio, G. D., Flores‐Mireles, A. L., Calix, J. J., Haurat, M. F., Scott, N. E., Palmer, L. D., Potter, R. F., Hibbing, M. E., Friedman, L. E., Wang, B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10706-y · Cited by 136
The Microbiome as a Component of the Tumor Microenvironment
Kovàcs, T., Mikó, E., Ujlaki, G., Sári, Z., & Bai, P. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35727-6_10 · Cited by 140
Microbiota Effects on Carcinogenesis: Initiation, Promotion, and Progression
Lopez, L. R., Bleich, R. M., & Arthur, J. C. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-080719-091604 · Cited by 148
Self-citationMéndez, R., Kesh, K., Arora, N., Martino, L. D., McAllister, F. M., Merchant, N. B., Banerjee, S., & Banerjee, S. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz116 · Cited by 133
Sadrekarimi, H., Gardanova, Z. R., Bakhshesh, M., Ebrahimzadeh, F., Yaseri, A. F., Thangavelu, L. P., Hasanpoor, Z., Zadeh, F. A., & Kahrizi, M. S. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03492-7 · Cited by 142
Apopa, P. L., Alley, L., Penney, R. B., Arnaoutakis, K., Steliga, M. A., Jeffus, S., Bircan, E., Gopalan, B., Jin, J., Patumcharoenpol, P., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01757 · Cited by 134
“Recent studies have shown that stress due to environmental factors can alter patients lung microbiome (Pauly and Paszkiewicz, 2011; Garmendia et al., 2012; Dickson et al., 2013; Fulbright et al., 2017).”
BackgroundLithocholic Acid, a Metabolite of the Microbiome, Increases Oxidative Stress in Breast Cancer
Kovács, P., Csonka, T., Kovàcs, T., Sári, Z., Ujlaki, G., Sipos, A. A., Karányi, Z., Szeőcs, D., Hegedűs, C., Uray, K., et al. (2019) · Cancers · doi:10.3390/cancers11091255 · Cited by 126
Costa, D. A., Nobre, J. G., Batista, M. V., Ribeiro, C., Callé, C., Cortés, A., Marhold, M., Negreiros, I., Borralho, P., Brito, M., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.584332 · Cited by 140
“As a result of the inactivation of E-cadherin, there is a nuclear translocation of ß-catenin, transcription of proto-oncogene c-Myc, and cellular hyperplasia (Fulbright et al., 2017).”
BackgroundInfluentialPiqué, N., Gómez-Guillén, M. C., & Montero, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030673 · Cited by 127
“At intestinal level, an increasing number of studies characterizing the intestinal gut microbiota have shown that perturbations of gut microbiota are associated with the development of different diseases, such as colorectal cancer [7,8], Crohn’s disease [9], irritable bowel syndrome (IBS) [10],”
BackgroundA detailed insight of the tumor targeting using nanocarrier drug delivery system
Batool, S., Sohail, S., Din, F. U., Alamri, A. H., Alqahtani, A. S., Alshahrani, M. A., Alshehri, M. A. S., & Choi, H. G. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2183815 · Cited by 125
“These defective genes cause the development of tumorous cells, which have the exclusive properties of abnormal cell growth, the incapability to stop unnecessary cell division, inhibition of apoptotic cell death, and the capacity to infiltrate nearby and far-off tissues (Fulbright et al., 2017).”
BackgroundSun, J., Chen, F., & Wu, G. (2023) · The ISME Journal · doi:10.1038/s41396-023-01483-0 · Cited by 126
Translational Roadmap for the Organs-on-a-Chip Industry toward Broad Adoption
Allwardt, V., Ainscough, A. J., Viswanathan, P., Sherrod, S. D., McLean, J. A., Haddrick, M., & Pensabene, V. (2020) · Bioengineering · doi:10.3390/bioengineering7030112 · Cited by 88
The Oral Mouse Microbiome Promotes Tumorigenesis in Oral Squamous Cell Carcinoma
Stashenko, P., Yost, S. C., Choi, Y., Danciu, T., Chen, T., Yoganathan, S., Kressirer, C. A., Ruiz-Tourrella, M., Das, B., Kokaras, A. S., et al. (2019) · mSystems · doi:10.1128/msystems.00323-19 · Cited by 86
“, sustaining proliferative signaling, increasing genome instability, and mutation rates) (38).”
BackgroundMicrobial Alterations and Risk Factors of Breast Cancer: Connections and Mechanistic Insights
Parida, S., & Sharma, D. (2020) · Cells · doi:10.3390/cells9051091 · Cited by 81
“It is interesting to note that the microbiota can affect Hanahan and Weinberg’s widely accepted hallmarks of cancer [30].”
BackgroundPellegrini, M., Ippolito, M., Monge, T., Violi, R., Cappello, P., Ferrocino, I., Cocolin, L. S., De Francesco, A., Bo, S., & Finocchiaro, C. (2020) · Nutrition · doi:10.1016/j.nut.2020.110749 · Cited by 77
“highly dysregulated during carcinogenesis (13).”
Tibbs, T. N., Lopez, L. R., & Arthur, J. C. (2019) · Microbial Cell · doi:10.15698/mic2019.08.685 · Cited by 68
“Direct effects of the microbiota on tumorigenesis Specific members of the microbiota have the capacity to directly contribute to tumorigenesis [2, 59].”
BackgroundSelf-citationDorelli, B., Gallé, F., Vito, C. D., Duranti, G., Iachini, M., Zaccarin, M., Standoli, J. P., Ceci, R., Romano, F., Liguori, G., et al. (2021) · Nutrients · doi:10.3390/nu13061890 · Cited by 75
Giron, L. B., Peluso, M. J., Ding, J., Kenny, G., Zilberstein, N., Koshy, J., Hong, K. Y., Rasmussen, H. E., Miller, G. E., Bishehsari, F., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.160989 · Cited by 79
“…the preexisting microbial translocation and chronic inflammation during HIV infection (115–126), after surviving Ebola disease (128), and/or during other aging-related conditions (104–114) contribute to PASC warrants further investigation using longitudinal samples before and after acute COVID-19.”
Ramirez, M. U., Hernandez, S. R., Soto‐Pantoja, D. R., & Cook, K. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010169 · Cited by 63
“Recent studies have even demonstrated that microbial flora in cancers differ from normal tissues, and these enhance tumor progression [9].”
BackgroundToll Like Receptors as Sensors of the Tumor Microbial Dysbiosis: Implications in Cancer Progression
Noci, V. L., Bernardo, G., Bianchi, F., Tagliabue, E., Sommariva, M., & Sfondrini, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.732192 · Cited by 63
Bautista, J., Maceiras, M. L., Hidalgo‐Tinoco, C., Guerra-Guerrero, A., Betancourt-Velarde, A., & López‐Cortés, A. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00883-8 · Cited by 77
Integrating the Tumor Microenvironment into Cancer Therapy
Sanegre, S., Lucantoni, F., Burgos‐Panadero, R., de la Cruz‐Merino, L., Noguera, R., & Naranjo, T. Á. (2020) · Cancers · doi:10.3390/cancers12061677 · Cited by 61
Microbiome and colorectal carcinogenesis: Linked mechanisms and racial differences
Tortora, S. C., Bodiwala, V., Quinn, A., Martello, L. A., & Vignesh, S. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i2.375 · Cited by 64
Role of Gut Microbiota in Breast Cancer and Drug Resistance
Sathiyapriya, V., Parida, S., Lingipilli, B. T., Ramalingam, K., Podipireddy, D. R., & Muniraj, N. (2023) · Pathogens · doi:10.3390/pathogens12030468 · Cited by 65
“The gut microbiome contributes to tumor initiation and progression by inducing tumor-promoting inflammation, or by modulating the local tumor microenvironment through its effects on tissue remodeling and mucosal immunity [18].”
BackgroundElie, C., Perret, M., Hage, H., Sentausa, E., Hesketh, A., Louis, K., Fritah, A., Leissner, P., Vachon, C., Rostaing, H., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-33959-6 · Cited by 62
Rathje, K., Mortzfeld, B. M., Hoeppner, M. P., Taubenheim, J., Bosch, T. C. G., & Klimovich, A. V. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008375 · Cited by 54
“A causal connection between microbiota and cancerogenesis is being increasingly appreciated [58,59].”
BackgroundHarness the functions of gut microbiome in tumorigenesis for cancer treatment
Lee, M. (2021) · Cancer Communications · doi:10.1002/cac2.12200 · Cited by 50
“In general, when dysbiosis of microbiota occurs in several organs, it may contribute to epithelial barrier breach as well as reprogram immune and metabolic signaling, including affecting other hallmarks of cancer [9], such as causing inflammation, regulating cellular proliferation and apoptosis, instigating genome ins…”
BackgroundRole of the microbiome in oral cancer occurrence, progression and therapy
Li, Z., Liu, Y., & Zhang, L. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105638 · Cited by 55
Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?
Zha, C., Peng, Z., Huang, K., Tang, K., Wang, Q., Zhu, L. J., Che, B., Li, W., Xu, S., Huang, T., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1196217 · Cited by 51
“Fusobacterium nucleatum promotes tumor growth by inhibiting T cell activity, which is associated with survival and antitumor therapeutic efficacy (96).”
BackgroundParasite-microbe-host interactions and cancer risk
Dheilly, N. M., Ewald, P. W., Brindley, P. J., Fichorova, R. N., & Thomas, F. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007912 · Cited by 47
“Evidence is accumulating that members of the gut, oral, and vaginal microbiomes could initiate or influence the progression of oncogenesis by different processes, including the induction of a chronic inflammatory state or immune response, altering stem cell dynamics, the biosynthesis of toxic and genotoxic metabolites…”
BackgroundŁaniewski, P., Cui, H., Roe, D. J., Chase, D. M., & Herbst‐Kralovetz, M. M. (2020) · npj Precision Oncology · doi:10.1038/s41698-020-0126-x · Cited by 51
Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer
Malla, R. R., Marni, R., Kumari, S., Chakraborty, A., & Pappu, L. (2021) · Clinical Breast Cancer · doi:10.1016/j.clbc.2021.09.002 · Cited by 46
Bacterial Extracellular Vesicles in Gastrointestinal Tract Cancer: An Unexplored Territory
Amatya, S. B., Salmi, S., Kainulainen, V., Karihtala, P., & Reunanen, J. (2021) · Cancers · doi:10.3390/cancers13215450 · Cited by 45
“A human host harbors about around 1013–1014 bacteria in his/her body, with the colon accommodating the highest number as reviewed in [7,13,90].”
BackgroundXu, Y., Zhao, J., Ma, Y., Liu, J., Cui, Y., Yuan, Y., Xiang, C., Ma, D., & Liu, H. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1100873 · Cited by 39
“Microbial communities can act as a source of activating signals for aberrant epithelial cell proliferation, initiating cancer (Fulbright et al., 2017).”
BackgroundModulation of Anti-Tumour Immune Responses by Probiotic Bacteria
Aindelis, G., & Chlichlia, K. (2020) · Vaccines · doi:10.3390/vaccines8020329 · Cited by 43
“As a result, the microbiota can be regarded as either tumorigenic or tumour-suppressive, depending on the circumstance, and its regulation and maintenance is crucial for the overall health of the host [25,26].”
BackgroundMolecular crosstalk between polyphenols and gut microbiota in cancer prevention
Zeb, F., Naqeeb, H., Osaili, T. M. I., Faris, M. E., Ismail, L. C., Obaid, R. S., Naja, F., Radwan, H. M., Hasan, H. A., Hashim, M. S., et al. (2024) · Nutrition Research · doi:10.1016/j.nutres.2024.01.012 · Cited by 40
Elsalem, L., Jum’ah, A. A., Alfaqih, M. A., & Aloudat, O. (2020) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s243337 · Cited by 39
Fernández-Murga, M. L., Gil-Ortiz, F., Serrano-García, L., & Llombart‐Cussac, A. (2023) · Pathogens · doi:10.3390/pathogens12091086 · Cited by 37
Intestinal bacterial biofilms modulate mucosal immune responses
Sartor, R. B. (2018) · Journal of Immunological Sciences · doi:10.29245/2578-3009/2018/2.1122 · Cited by 41
The Pivotal Player: Components of NF-κB Pathway as Promising Biomarkers in Colorectal Cancer
Martin, M., Sun, M., Motolani, A., & Lu, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147429 · Cited by 36
“These interactions and overall dysregulation of signaling pathways in CRC can lead to increased tumorigenesis as well as increasing the so-called “hallmarks of cancer” [42].”
BackgroundNicolò, S., Antonelli, A., Tanturli, M., Baccani, I., Bonaiuto, C., Castronovo, G., Rossolini, G. M., Mattiuz, G., & Torcia, M. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087173 · Cited by 33
Nutrition Intervention and Microbiome Modulation in the Management of Breast Cancer
Jiang, Y., & Li, Y. (2024) · Nutrients · doi:10.3390/nu16162644 · Cited by 41
“The gut microbiome is considered a double-edged sword because of its contribution to tumor-promoting inflammation and its protective effects on regulating the anticancer immune response [5].”
BackgroundThe Endometrial Microbiota: Challenges and Prospects
Bwanga, P. K., Tremblay-Lemoine, P.-L., Timmermans, M., Ravet, S., Munaut, C., Nisolle, M., & Henry, L. (2023) · Medicina · doi:10.3390/medicina59091540 · Cited by 39
“nucleatum in colorectal cancer) through the activation of Toll-like receptors and nucleotide-binding oligomerization domain-like receptors [54].”
BackgroundThe oral-gut-circulatory axis: from homeostasis to colon cancer
Tortora, S. C., Agurto, M. I. G., & Martello, L. A. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1289452 · Cited by 35
“Several studies have highlighted the relationship between the gut microbiota and colon cancer (Cho et al., 2014; Fulbright et al., 2017; Koliarakis et al., 2019; Tortora et al., 2022).”
BackgroundGut Microbiota and Cancer of the Host: Colliding Interests
Baffy, G. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_5 · Cited by 32
Merali, N., Chouari, T. A. M., Kayani, K., Rayner, C. J., Jiménez, J. I., Krell, J., Giovannetti, E., Bagwan, I., Relph, K., Rockall, T., et al. (2022) · Cancers · doi:10.3390/cancers14041020 · Cited by 29
“It has been postulated that “driver” microbes that initiate colorectal cancer development are followed by “passenger” microbes, which have a growth advantage in the environment established by the drivers [8,73,74].”
BackgroundWallace, T. C., Bultman, S. J., D’Adamo, C. R., Daniel, C. R., Debelius, J. W., Ho, E., Eliassen, A. H., Lemanne, D., Mukherjee, P., Seyfried, T. N., et al. (2018) · Journal of the American College of Nutrition · doi:10.1080/07315724.2018.1500499 · Cited by 28
“metabolism, inflammation, and tumorigenesis (36, 37).”
Piciocchi, A., Germinario, E. A. P., García‐Etxebarria, K., Rossi, S., Sanchez-Mete, L., Porowska, B., Stigliano, V., Trentino, P., Oddi, A., Accarpio, F., et al. (2021) · Toxins · doi:10.3390/toxins13080569 · Cited by 29
“In addition to the environmental and genetic factors, microbial dysbiosis also influences the hallmarks of cancer [4], as does inflammation, which is strongly linked to the gut microbiota.”
BackgroundKim, S., Kim, Y., Lee, S., Kim, Y., Jeon, B., Kim, H., & Park, H. (2022) · Cancers · doi:10.3390/cancers14174083 · Cited by 30
“Additionally, metabolites produced by the microbiome, such as toxins, PAMPs, and shortchain fatty acids, can suppress tumor growth by having cytotoxic effects on rapidly replicating cancer cells or by inhibiting angiogenesis [6,7].”
BackgroundMicrobiota Regulates Pancreatic Cancer Carcinogenesis through Altered Immune Response
Chai, Y., Huang, Z., Shen, X., Lin, T., Zhang, Y., Xu, F., Mao, Q., & Liang, Y. (2023) · Microorganisms · doi:10.3390/microorganisms11051240 · Cited by 29
“microenvironment (TME) locally through interactions with immune responses, hence, influencing cancer initiation, development, and treatment, and the effects range from harmful to beneficial [18,36,37].”
BackgroundHe, J., Li, H., Jia, J., Liu, Y., Zhang, N., Wang, R., Qu, W., Liu, Y., & Jia, L. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00157-9 · Cited by 34
“…protecting the intestinal mucosa from pathogens within the intestines, and preventing pathogenic bacteria from escaping from the intestines into other tissues [4] The intestinal microbiota is also closely related to many diseases such as metabolic syndrome [5], depression [6], and tumours [7].”
BackgroundLäsche, M., Urban, H., Gallwas, J. K. S., & Gründker, C. (2021) · Cells · doi:10.3390/cells10030714 · Cited by 28
“The effects of probiotic microorganisms on tissue health or possible disease progression through dysbiotic bacteria are largely determined by the integrity of the mucosal epithelium [2,51,54,55].”
BackgroundMulti-Omic Approaches in Colorectal Cancer beyond Genomic Data
Sardo, E., Napolitano, S., Corte, C. M. D., Ciardiello, D., Raucci, A., Arrichiello, G., Troiani, T., Ciardiello, F., Martinelli, E., & Martini, G. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020128 · Cited by 28
Early-life vancomycin treatment promotes airway inflammation and impairs microbiome homeostasis
Yang, X., Feng, H., Zhan, X., Zhang, C., Cui, R., Zhong, L., Ying, S., & Chen, Z. (2019) · Aging · doi:10.18632/aging.101901 · Cited by 25
Resistance mechanisms in melanoma to immuneoncologic therapy with checkpoint inhibitors
Fenton, S. E., Sosman, J. A., & Chandra, S. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.28 · Cited by 37
“Butyrate can also act as a histone deacetylase inhibitor to promote apoptosis and inhibit proliferation([181]).”
BackgroundThe microbiome in pediatric oncology
Rotz, S. J., & Dandoy, C. E. (2020) · Cancer · doi:10.1002/cncr.33030 · Cited by 25
“The microbiota influences neoplasia by modifying the local tumor microenvironment via effects on mucosal immunity and local tissue remodeling.(65)”
BackgroundNiccolai, E., Boem, F., Emmi, G., & Amedei, A. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.03.001 · Cited by 23
“ment having impact on different “hallmarks of cancer”, including the modulation of anticancer immunity [164,165].”
BackgroundRandomized Trial of Perioperative Probiotics Among Patients Undergoing Major Abdominal Operation
Franko, J., Raman, S. R., Krishnan, N., Frankova, D., Tee, M. C., Brahmbhatt, R. A., Goldman, C. D., & Weigel, R. J. (2019) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2019.09.002 · Cited by 21
Pearls collections: What we can learn about infectious disease and cancer
Knoll, L. J., Hogan, D. A., Leong, J. M., Heitman, J., & CONDIT, R. C. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006915 · Cited by 19
“Fulbright et al. (2017) [16] examine the potential roles for bacteria in tumorigenesis utiliz- ing—as a start—a framework set forth by Hanahan and Weinburg [17] that describes the progression of a normal cell in a healthy context to a cancer cell in a complex tumor environment.”
BackgroundDiMaio, D., Emu, B., Goodman, A. L., Mothes, W., & Justice, A. C. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab212 · Cited by 24
Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition
Guardamagna, M., Berciano‐Guerrero, M., González, B. V., Pérez-Ruiz, E., Oliver, J., Lavado-Valenzuela, R., Rueda‐Domínguez, A., Barragán, I., & Queipo‐Ortuño, M. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911990 · Cited by 18
“Fusobacterium nucleatum also acts in this pathway by linking E-cadherin to an adhesin called FadA, releasing ß-catenin [60].”
BackgroundAssociation between vaginal microbiota and the progression of ovarian cancer
Li, C., Feng, Y., Yang, C., Wang, D., Zhang, D., Luo, X., Zhang, H., Huang, H., Zhang, H., Jiang, Y., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28898 · Cited by 20
“Our study also elucidated candidate microbial taxa, such as Acinetobacter and Burkholderia, that tended to spread across the genital tract, which may cause local microenvironment disturbance via microbe‐mediated pathophysiological changes, including chronic inflammation, barrier disruption, genomic instability, altere…”
BackgroundGut microbiota and immunotherapy of renal cell carcinoma
Bibbò, S., Porcari, S., Vecchio, L. E. D., Severino, A., Mullish, B. H., Ianiro, G., Gasbarrini, A., & Cammarota, G. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2268982 · Cited by 20
“20 Several studies have clarified the intrinsic relationship between microbiome and cancer, 22 and consequently the microbiome can be considered as a fundamental actor in cancer development and as modifier of therapeutic efficacy and safety.”
BackgroundReview of nutritional status, body composition, and effects of antineoplastic drug disposition
Wiernikowski, J. T., & Bernhardt, M. B. (2020) · Pediatric Blood & Cancer · doi:10.1002/pbc.28207 · Cited by 20
Harnessing Tissue Engineering Tools to Interrogate Host-Microbiota Crosstalk in Cancer
Udayasuryan, B., Nguyen, T. T. D., Slade, D. J., & Verbridge, S. S. (2020) · iScience · doi:10.1016/j.isci.2020.101878 · Cited by 16
Gu, C., Sha, G., Zeng, B., Cao, H., Cao, Y., & Tang, D. (2025) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848251327167 · Cited by 17
New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge?
Rapti, V., Τσαγανός, Θ., Vathiotis, I. A., Syrigos, N. K., Li, P., & Poulakou, G. (2022) · Vaccines · doi:10.3390/vaccines10101607 · Cited by 16
“In the context of cancer, ample evidence suggests the duality in the role of gut microbiota, since it can be either tumor-promoter or tumor-suppressor [87,88].”
BackgroundQuantitative Metabolomics to Explore the Role of Plasma Polyamines in Colorectal Cancer
Coradduzza, D., Arru, C., Culeddu, N., Congiargiu, A., Azara, E., Scanu, A. M., Zinellu, A., Muroni, M. R., Rallo, V., Medici, S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010101 · Cited by 17
“In recent years, the role of gut microbiome and its dysbiosis is becoming clearer in cancer development [34].”
BackgroundThe potential of fecal microbiota transplantation in oncology
Lythgoe, M. P., Ghani, R., Mullish, B. H., Marchesi, J. R., & Krell, J. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.10.003 · Cited by 14
Acar, C., Küçükyıldırım, S., Özdemirel, H. Ö., Erdem, B., Alan, S., & Mergen, H. (2023) · Folia Microbiologica · doi:10.1007/s12223-023-01072-w · Cited by 13
“…studies suggested that microorganisms may contribute to tumorigenesis by different mechanisms including DNA damage, cell proliferation, production of carcinogenic metabolites, and chronic inflammation (Schwabe and Jobin 2013; Dzutsev et al. 2015; Johnson et al. 2016; Fulbright et al. 2017).”
Cardeña-Gutiérrez, A., & Barahona, M. L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.908752 · Cited by 14
“Nuclear factor kappa B (NF-κB) activation is essential for Treg-induced homeostasis, and Treg and effector T-cell expansion (21).”
BackgroundThe interaction of gut microbiota with parasitic protozoa
Bağcı, Ö. U., & Caner, A. (2021) · Journal of Parasitic Diseases · doi:10.1007/s12639-021-01443-5 · Cited by 13
Cancerogenic parasites in veterinary medicine: a narrative literature review
Fonti, N., Parisi, F., Mancianti, F., Freer, G., & Poli, A. (2023) · Infectious Agents and Cancer · doi:10.1186/s13027-023-00522-x · Cited by 12
The Human OncoBiome Database: A Database of Cancer Microbiome Datasets
Nadia, N., & Ramana, J. (2019) · Current Bioinformatics · doi:10.2174/1574893614666190902152727 · Cited by 10
Gut Microbiome and the Response to Immunotherapy in Cancer
Stancu, A. L. (2018) · Discoveries · doi:10.15190/d.2018.4 · Cited by 14
Bladder cancer microbiome and its association with chemoresponse
Ginwala, R., Bukavina, L., Sindhani, M., Nachman, E. J., Peri, S., Franklin, J., Drevik, J. A., Christianson, S. S., Geynisman, D. M., Kutikov, A., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1506319 · Cited by 12
“Microbial dysbiosis has been associated with several diseases including infectious diseases, metabolic disorders, gastrointestinal (GI) abnormalities, and cancer (2, 3).”
Mahoney, D. E., Chalise, P., Rahman, F. K., & Pierce, J. D. (2022) · Cancers · doi:10.3390/cancers14123022 · Cited by 10
“Microorganisms have been shown to modulate known human host factors that comprise the hallmarks of cancer [20].”
BackgroundJahić, M., & Cerovac, A. (2022) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog4908169 · Cited by 15
Bose, D., Banerjee, S., Singh, R. K., Wise, L. M., & Robertson, E. S. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03203-4 · Cited by 11
Gut Feelings: The Microbiome and Our Health
Fasano, A., & Flaherty, S. (2021) · The MIT Press eBooks · doi:10.7551/mitpress/11291.001.0001 · Cited by 14
Research progress on the mitochondrial mechanism of age-related non-alcoholic fatty liver
Wang, D., Ji, D.-C., Yu, C., Wu, D., & Qi, L. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i13.1982 · Cited by 10
Survival and cancer recurrence after short-course perioperative probiotics in a randomized trial
Franko, J., Raman, S. R., Patel, S., Petree, B. S., Lin, M., Tee, M. C., Le, V. H., & Frankova, D. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.01.003 · Cited by 9
Wu, H., Liu, Q., Li, J., Leng, X., He, Y., Liu, Y., Zhang, X., Ouyang, Y., Liu, Y., Liang, W., et al. (2024) · Advanced Science · doi:10.1002/advs.202309742 · Cited by 13
Sharma, A. D., Jarman, E. H., Kuppalli, K., Murphy, M. P., Longaker, M. T., Gurtner, G. C., & Fox, P. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-54477-z · Cited by 7
“Similarly, the presence or absence of certain co-morbid conditions, such as diabetes and cancer, can dramatically alter the microbial composition of chronic wounds 4–6 .”
Background
Metadata
- Authors
- Fulbright, L. E., Ellermann, M., & Arthur, J. C.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Arthur, Janelle C.
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-09-21
- Volume
- 13
- Issue
- 9
- Pages
- e1006480
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC5608396
- OpenAlex
- W2759449520
- Cited by
- 164
- References
- 160
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 21 · 2023: 19 · 2022: 21 · 2021: 21 · 2020: 24 · 2019: 20 · 2018: 9
- FWCI
- 5.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK103952)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Keywords
- gut microbiota, cancer hallmarks, cell proliferation, E-cadherin, Wnt/β-catenin signaling, Bacteroides fragilis, enterotoxigenic Bacteroides fragilis, intestinal epithelial cells, tissue homeostasis
- MeSH terms
- Animals, Humans, Neoplasms, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
